Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 2.12 is 69% below its 5-year average of 6.90, near the low end of its 5-year range (1.40–15.87).
As of the fiscal period ended Tuesday, June 30, 2026. 6.74% above its 12-month average of 1.99.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.12.
QUICK RATIO (ACID-TEST)
2.12
QUICK RATIO (ACID-TEST) AVG TTM
1.99
QUICK RATIO (ACID-TEST) AVG 3Y
4.10
QUICK RATIO (ACID-TEST) AVG 5Y
6.90
QUICK RATIO (ACID-TEST) AVG 10Y
4.62
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+6.74%
CURRENT VS 3Y AVG
-48.28%
CURRENT VS 5Y AVG
-69.25%
CURRENT VS 10Y AVG
-54.10%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
-36.78%
vs the sector median at left
Liquidia Corporation
Market Cap
$2.30B
Quick Ratio (Acid-Test)
2.12
TTM Avg
1.99
3Y Avg
4.10
5Y Avg
6.90
Market Cap
$2.28B
Quick Ratio (Acid-Test)
3.45
TTM Avg
3.42
3Y Avg
3.65
5Y Avg
3.62
Market Cap
$2.34B
Quick Ratio (Acid-Test)
1.72
TTM Avg
1.46
3Y Avg
1.33
5Y Avg
1.71
Market Cap
$2.35B
Quick Ratio (Acid-Test)
6.34
TTM Avg
6.74
3Y Avg
5.35
5Y Avg
5.47
Market Cap
$2.36B
Quick Ratio (Acid-Test)
3.81
TTM Avg
3.32
3Y Avg
2.77
5Y Avg
2.91
Market Cap
$2.37B
Quick Ratio (Acid-Test)
24.14
TTM Avg
21.55
3Y Avg
17.24
5Y Avg
12.65
Market Cap
$2.24B
Quick Ratio (Acid-Test)
10.23
TTM Avg
3.96
3Y Avg
3.96
5Y Avg
3.96
Market Cap
$2.38B
Quick Ratio (Acid-Test)
1.50
TTM Avg
1.54
3Y Avg
1.54
5Y Avg
1.56
Market Cap
$2.43B
Quick Ratio (Acid-Test)
5.03
TTM Avg
4.66
3Y Avg
4.92
5Y Avg
7.11
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Liquidia Corporation (LQDA) | $2.30B | 2.12 | 1.99 | 4.10 | 6.90 |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.28B | 3.45 | 3.42 | 3.65 | 3.62 |
| UFP Technologies, Inc. (UFPT)vs › | $2.34B | 1.72 | 1.46 | 1.33 | 1.71 |
| Nurix Therapeutics, Inc. (NRIX)vs › | $2.35B | 6.34 | 6.74 | 5.35 | 5.47 |
| ADMA Biologics, Inc. (ADMA)vs › | $2.36B | 3.81 | 3.32 | 2.77 | 2.91 |
| Disc Medicine, Inc. (IRON)vs › | $2.37B | 24.14 | 21.55 | 17.24 | 12.65 |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.24B | 10.23 | 3.96 | 3.96 | 3.96 |
| Clover Health Investments, Corp. (CLOV)vs › | $2.38B | 1.50 | 1.54 | 1.54 | 1.56 |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.43B | 5.03 | 4.66 | 4.92 | 7.11 |
| Pharvaris N.V. (PHVS)vs › | $2.17B | 11.94 | 11.36 | 14.72 | 18.03 |
Quick Ratio
2.12
Excludes inventory
Current Ratio
2.31
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 2.12 |
| 2026-03-31 | 2.03 |
| 2025-12-31 | 1.40 |
| 2025-09-30 | 1.96 |
| 2025-06-30 | 2.41 |
| 2025-03-31 | 2.91 |
| 2024-12-31 | 4.42 |
| 2024-09-30 | 6.33 |
| 2024-06-30 | 5.78 |
| 2024-03-31 | 7.50 |
| 2023-12-31 | 4.85 |
| 2023-09-30 | 6.83 |
| 2023-06-30 | 4.76 |
| 2023-03-31 | 14.62 |
| 2022-12-31 | 11.34 |
| 2022-09-30 | 13.81 |
| 2022-06-30 | 15.87 |
| 2022-03-31 | 7.77 |
| 2021-12-31 | 8.36 |
| 2021-09-30 | 9.55 |
| 2021-06-30 | 10.23 |
| 2021-03-31 | 6.99 |
| 2020-12-31 | 5.63 |
| 2020-09-30 | 5.67 |
| 2020-06-30 | 1.83 |
| 2020-03-31 | 2.55 |
| 2019-12-31 | 3.34 |
| 2019-09-30 | 2.87 |
| 2019-06-30 | 4.32 |
| 2019-03-31 | 5.57 |
| 2018-12-31 | 4.85 |
| 2018-09-30 | 6.27 |
| 2018-06-30 | 0.66 |
| 2018-03-31 | 1.30 |
| 2017-12-31 | 0.18 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
